Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.965 USD | +15.59% | +14.53% | +242.61% |
01:46pm | Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study | MT |
May. 14 | Transcript : Ocugen, Inc., Q1 2024 Earnings Call, May 14, 2024 |